Skip to main content
Clinical Trials/JPRN-UMIN000027941
JPRN-UMIN000027941
Recruiting
未知

Exploratory research on efficacy and safety of transarterial chemo-embolization with warmed miriplatin for unresectable hepatocellular carcinoma - efficacy and safety of TACE with warmed miriplatin for unresectable HCC

The University of Tokyo0 sites30 target enrollmentJune 28, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Tokyo
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 28, 2017
End Date
May 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) severly impaired liver function (Child\-Pugh C) 2\) jaundice with T\-bil \>\=3mg/dL 3\) severely impaired renal function (eGFR \< 30 mL/min/1\.73m2\) 4\) past history with allergy or severe adverse events after TACE 5\) marked history of hypersensitivity to miriplatin, other platinum\-containing drugs or iodine\-containing drugs 6\) uncontrolled severe thyroid disorder 7\) pregnant, lactating 8\) dementia with difficuty conducting TACE 9\) patients judged inadequate by investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials